We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

IO2.0 ADC2.0

Advertisement

cGxPJobs Banner

Akeso Doses First Patient in HER3 ADC Lung Cancer Trial

Hong Kong, July 27, 2026 Akeso, Inc. has announced that the first patient has been dosed in the Phase...

By cGxPwire Editor
July 29, 2026

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

Thermo Fisher Launches AmpSure Universal qPCR Master Mixes
November 7, 2026
02

Bio-Pharma

Biohaven Advances Pivotal Phase 3 Trial for Graves’ Disease
November 7, 2026
03

MedTech

Nuvo REACTIVE Trial Shows Gains in At-Home Fetal Monitoring
November 7, 2026
04

Pharma

Amgen Reports 20% Lower Heart Attack Risk With Repatha
November 7, 2026
05

Bio-Pharma

Zydus Reports Positive Phase 2b Saroglitazar MASH Data
November 7, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website